MSB 1.86% $1.32 mesoblast limited

banter and General Discussion, page-4777

  1. 15,721 Posts.
    lightbulb Created with Sketch. 5747
    Of course that is your opinion .... I would expect nothing less than doom and gloom from a known MSB critic ... lol

    You like many naysayers on here fail to acknowledge that the additional data from the 241 patients treated with Remestemcel-L through the FDA approved EAP will dramatically improve the BLA resubmission's chances .... you also fail to comprehend that the number 241 represents a figure far greater than any number of participants in any trial undertaken by Mesoblast for SR-aGVHD so one could form the view that Mesoblast have basically completed another trial anyway

    upload_2022-9-28_9-47-5.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.